Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine

The 22q11.2 deletion syndrome (22q11.2DS) confers high risk of neurodevelopmental disorders such as schizophrenia and attention-deficit hyperactivity disorder. These disorders are associated with attentional impairment, the remediation of which is important for successful therapeutic intervention. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Simon R. O., Heath, Christopher J., Takillah, Samir, Didienne, Steve, Fejgin, Kim, Nielsen, Vibeke, Nielsen, Jacob, Saksida, Lisa M., Mariani, Jean, Faure, Philippe, Didriksen, Michael, Robbins, Trevor W., Bussey, Timothy J., Mar, Adam C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235862/
https://www.ncbi.nlm.nih.gov/pubmed/30429456
http://dx.doi.org/10.1038/s41398-018-0295-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235862/
https://www.ncbi.nlm.nih.gov/pubmed/30429456
http://dx.doi.org/10.1038/s41398-018-0295-3

Ejemplares similares